Search This Blog

Thursday, January 17, 2019

Quest Diagnostics initiated at UBS


Quest Diagnostics initiated with a Neutral at UBS. UBS analyst Kevin Caliendo started Quest Diagnostics with a Neutral rating and $90 price target.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)